Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers
NCT04077372 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2023-01-27
Summary
The purpose of the study is to determine whether standardized implementation of a scripted template for discussing important issues that arise near the end of life improves the care of those who have advanced cancer.
Conditions
- Gastrointestinal Cancer
- Colorectal Cancer
- Pancreatic Adenocarcinoma
- Gastric Cancer
- Esophageal Cancer
- Cholangiocarcinoma
- Hepatocellular Carcinoma
- Neuroendocrine Tumors
- GIST, Malignant
Interventions
- BEHAVIORAL
-
Serious Illness Conversation Guide (SICG)
The Serious Illness Conversation Guide (SICG) is a structured communication template designed to provide effective tool in initiating advanced care planning discussion with patients.
- BEHAVIORAL
-
Quality of Life (QOL) survey
Quality of life survey by questionnaire (FACT-G) given every three months
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Tyler P Johnson, MD · Stanford University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-09-16
- Primary Completion
- 2020-10-11
- Completion
- 2020-10-11
Countries
- United States
Study Locations
More Related Trials
-
Carlizumab Plus Sovantinib in Second-line Treatment of Advanced or Metastatic Cholangiocarcinoma
NCT05697237 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Pegamotecan (PEG-Camptothecin) in Localized or Metastatic Cancer of the Stomach or Gastroesophageal Junction
NCT00080002 ·Status: TERMINATED ·Phase: PHASE2
-
A Novel Patient Engagement Platform Among Patients With Gastrointestinal Malignancies
NCT04316078 ·Status: COMPLETED ·Phase: NA
-
Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer
NCT00003172 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers
NCT05296005 ·Status: WITHDRAWN ·Phase: PHASE1
-
Fluorouracil, Cisplatin, Leucovorin Calcium, and Cetuximab in Treating Patients With Adenocarcinoma of the Stomach or Gastroesophageal Junction
NCT01360086 ·Status: COMPLETED ·Phase: PHASE2
-
Metastatic Gastric Cancer FFCD 03-07
NCT00374036 ·Status: COMPLETED ·Phase: PHASE3
-
FMT+SOX+Sintilimab As First-line Treatment for Advanced Gastric Cancer
NCT06405113 ·Status: RECRUITING ·Phase: PHASE2
-
Maintenance Treatment With S-1 in Gastric Cancer Patients
NCT03701373 ·Status: UNKNOWN ·Phase: PHASE2
-
S-1 Plus Oxaliplatin Compared With Fluorouracil, Leucovorin Calcium Plus Oxaliplatin as Perioperative Chemotherapy for Advanced Gastric Carcinoma
NCT01364376 ·Status: COMPLETED ·Phase: NA
-
A Study of Perioperative mFOLFOX6 Plus Pembrolizumab in Patients With Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction (GEJ) and Stomach
NCT02943603 ·Status: WITHDRAWN ·Phase: PHASE2
-
Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancer
NCT00006038 ·Status: COMPLETED ·Phase: PHASE2
-
Study of ZG005 in Combination With Gecacitinib and Chemotherapy for Participants With Advanced Solid Tumors
NCT07142837 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Intraperitoneal Chemotherapy Guided by the Detection of DNA in Peritoneal Lavage Fluid in Patients With Gastric Cancer
NCT05497739 ·Status: UNKNOWN ·Phase: PHASE2
-
A Safety and Efficacy Study in Patients With Gastric Cancer
NCT00400179 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradiation
NCT04308837 ·Status: RECRUITING ·Phase: PHASE2
-
High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer
NCT00002722 ·Status: COMPLETED ·Phase: PHASE2
-
Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal Cancer
NCT04499924 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Phase III Study of Fruquintinib in Combination With Paclitaxel in Second Line Gastric Cancer(FRUTIGA)
NCT03223376 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric Cancer
NCT00072787 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer.
NCT00209729 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2
-
Neoadjuvant Chemotherapy With PISOXO for Locally-invaded-gastric Cancer (LIGC)
NCT04410887 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma
NCT01053390 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Sequential Systemic Therapy + Intraperitoneal Paclitaxel in Gastric/GEJ Peritoneal Carcinomatosis
NCT04762953 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Prospective Evaluation and Molecular Profiling in People With Gastric Tumors
NCT03027427 ·Status: COMPLETED